Quarterly Result31 Jan 2026, 03:52 pm
Hindustan Bio Sciences Ltd. Approves Q3 Results for FY2025-26 in Board Meeting
AI Summary
Hindustan Bio Sciences Ltd. held a Board Meeting on January 31, 2026, where they approved the un-audited financial results for the quarter ended 31st December 2025. The company's revenue from operations, total revenue, and profit before tax have been reported. The meeting also reviewed the Limited Review Report for the quarter ended 31st December 2025.
Key Highlights
- Hindustan Bio Sciences Ltd. approved the un-audited financial results for the quarter ended 31st December 2025.
- The company's revenue from operations, total revenue, and profit before tax have been reported.
- The Limited Review Report for the quarter ended 31st December 2025 was also reviewed.
- The meeting was held at the company's registered office in Hyderabad.
Price Impact
More from HINDBIO